Invitae, a medical genetics company, announced the availability of a testing program, Detect Hereditary Pancreatic Cancer, that offers no-charge genetic testing and counseling to patients with pancreatic cancer.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
